For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Research and development | 9,120 | 3,943* | 14,401 | 16,566 |
| General and administrative | 3,654 | 5,965* | 4,199 | 4,710 |
| Impairment of long-lived assets | - | -4,410* | 2,205 | - |
| Total operating expenses | 12,774 | 5,497 | 20,805 | 21,276 |
| Loss from operations | -12,774 | -5,497* | -20,805 | -21,276 |
| Change in fair value of common warrant liability | 581 | -4,964* | - | - |
| Gain on sale of property and equipment | 510 | - | - | - |
| Interest and other income, net | 430 | -5,543* | 4,398 | 536 |
| Net loss | - | -6,076 | - | - |
| Net and comprehensive loss | -12,415 | -6,076 | -16,407 | -20,740 |
| Basic EPS | -0.17 | -0.108 | -0.27 | -0.51 |
| Diluted EPS | -0.17 | -0.108 | -0.27 | -0.51 |
| Basic Average Shares | 72,299,440 | 56,205,476 | 59,848,325 | 40,630,403 |
| Diluted Average Shares | 72,299,440 | 56,205,476 | 59,848,325 | 40,630,403 |
Biomea Fusion, Inc. (BMEA)
Biomea Fusion, Inc. (BMEA)